NR4A1 and breast carcinoma: The main differences that breast cancer cells express and define in the treatment are the human epidermal growth factor receptor 2 (HER2-positive), hormone receptor-positive breast cancer, BRCA gene mutations, and triple-negative breast cancer (TNBC) [36].